Dr. Jeroen Mertens, Nucleaire Geneeskunde SRL
Dr. Jeroen Mertens, Nucleaire Geneeskunde reported total assets of 951,663 € at the end of the 2025 financial year (annual accounts filed with the NBB on 10 Jul 2026).
By total assets for 2025, Dr. Jeroen Mertens, Nucleaire Geneeskunde ranks among the 5,000 largest of the 15,438 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Dr. Jeroen Mertens, Nucleaire Geneeskunde shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -26 % Total assets +38 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Jeroen Mertens, Nucleaire Geneeskunde's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 455,424 € | ||||
| Equity | 225,299 € | ||||
| Cash | 704,602 € | ||||
| EBITDA | 596,314 € | ||||
| Total assets | 951,663 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jul 2026
- Year ended 31 Dec 2024filed on 22 Jul 2025
- Year ended 31 Dec 2023filed on 18 Apr 2024
- Year ended 31 Dec 2022filed on 04 Jul 2023
- Year ended 31 Dec 2021filed on 17 Oct 2022
Dr. Jeroen Mertens, Nucleaire Geneeskunde's financial analysis
- Solvency23.7%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Jeroen Mertens, Nucleaire Geneeskunde
1 active director(s) in the register.
Dr. Jeroen Mertens, Nucleaire Geneeskunde's shareholders and holdings →Dr. Jeroen Mertens, Nucleaire Geneeskunde's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0704.757.557
- VAT number
- BE0704757557
- Peppol
- Registered · 0208:0704757557 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Sep 2018
- Registered office
- 9000 Ghent
- Latest accounts
- 2025 · filed on 10 Jul 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr. Jeroen Mertens, Nucleaire Geneeskunde (SRL) has been based in Ghent since 2018, active in: medical specialists activities. For 2025, it reports a net profit of 455,424 € and equity of 225,299 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. Jeroen Mertens, Nucleaire Geneeskunde
Companies in the same business, of comparable size and area, outside its group.
- Dr. Vaes Bart - Anesthesie Medical specialists activities Kruisem · balance sheet 948,485 €
- CDND Medical specialists activities Mons · balance sheet 952,536 €
- VD Medical specialists activities Arlon · balance sheet 944,269 €
- Dokter de Gouw Medical specialists activities Beersel · balance sheet 959,983 €
- DR. FR. URBAIN -CHIRURGIE PLASTIQUE ET ESTHéTIQUE Medical specialists activities Brussels · balance sheet 961,734 €
- Dr BOUWEN LUC Orthopedist Medical specialists activities Oosterzele · balance sheet 951,957 €
- Dr. Frederik Clement Medical specialists activities Roeselare · balance sheet 952,550 €
- FPOrthodontie Medical specialists activities Leuven · balance sheet 950,596 €
Frequently asked questions about Dr. Jeroen Mertens, Nucleaire Geneeskunde
What is the revenue of Dr. Jeroen Mertens, Nucleaire Geneeskunde?
Dr. Jeroen Mertens, Nucleaire Geneeskunde files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Jeroen Mertens, Nucleaire Geneeskunde?
In Belgium, the VAT number is the company number prefixed with BE: BE0704757557 for Dr. Jeroen Mertens, Nucleaire Geneeskunde, if the company is VAT-registered. Its company number (CBE) is 0704.757.557.
Where is the registered office of Dr. Jeroen Mertens, Nucleaire Geneeskunde?
According to the CBE register, the registered office of Dr. Jeroen Mertens, Nucleaire Geneeskunde is in 9000 Ghent.
What is the equity of Dr. Jeroen Mertens, Nucleaire Geneeskunde?
At the close of the 2025 financial year, the equity of Dr. Jeroen Mertens, Nucleaire Geneeskunde amounts to 225,299 €, a solvency of 23.7% of total assets.
Who manages Dr. Jeroen Mertens, Nucleaire Geneeskunde?
The register lists 1 active mandates at Dr. Jeroen Mertens, Nucleaire Geneeskunde. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Dr. Jeroen Mertens, Nucleaire Geneeskunde within its sector?
By total assets for 2025, Dr. Jeroen Mertens, Nucleaire Geneeskunde ranks among the 5,000 largest of the 15,438 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year.
The full file of Dr. Jeroen Mertens, Nucleaire Geneeskunde
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →